Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Lewis

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Nuclear Medicine and Biology|June 18, 2015
Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugateDijie Liu, Ethan R Balkin, Fang Jia, et al.
Cancer Research|October 30, 2003
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancerMu Wang, Amy L Caruano, Michael R Lewis, et al.
Nuclear Medicine and Biology|July 9, 2010
In vitro structure-activity relationship of Re-cyclized octreotide analoguesShorouk F Dannoon, Heather M Bigott-Hennkens, Lixin Ma, et al.
Archives of Pathology & Laboratory Medicine|January 24, 2019
Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow ExaminationLauren N Pearson, Jill M Miller, John H Lunde, et al.
Bioconjugate Chemistry|November 21, 2002
Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA bindingMichael R Lewis, Fang Jia, Fabio Gallazzi, et al.
Nuclear Medicine and Biology|January 30, 2021
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, <sup>99m</sup>Tc and <sup>186</sup>Re metal centers: Radiochemistry and in vitro evaluationJing Wang, George Makris, Marina Kuchuk, et al.
Nuclear Medicine and Biology|May 3, 2011
Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivativesHeather M Bigott-Hennkens, Shorouk F Dannoon, Samantha M Noll, et al.
Bioconjugate Chemistry|November 20, 2003
Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogeneFabio Gallazzi, Yi Wang, Fang Jia, et al.
Nuclear Medicine and Biology|December 10, 2014
Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)LuChi Soo Kang, Yunwei Chen, Hyunbeom Lee, et al.
Nuclear Medicine and Biology|November 26, 2013
Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemiaEthan R Balkin, Dijie Liu, Fang Jia, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Nuclear Medicine and Biology|June 18, 2015
Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugateDijie Liu, Ethan R Balkin, Fang Jia, et al.
Cancer Research|October 30, 2003
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancerMu Wang, Amy L Caruano, Michael R Lewis, et al.
Nuclear Medicine and Biology|July 9, 2010
In vitro structure-activity relationship of Re-cyclized octreotide analoguesShorouk F Dannoon, Heather M Bigott-Hennkens, Lixin Ma, et al.
Archives of Pathology & Laboratory Medicine|January 24, 2019
Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow ExaminationLauren N Pearson, Jill M Miller, John H Lunde, et al.
Bioconjugate Chemistry|November 21, 2002
Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA bindingMichael R Lewis, Fang Jia, Fabio Gallazzi, et al.
Nuclear Medicine and Biology|January 30, 2021
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, <sup>99m</sup>Tc and <sup>186</sup>Re metal centers: Radiochemistry and in vitro evaluationJing Wang, George Makris, Marina Kuchuk, et al.
Nuclear Medicine and Biology|May 3, 2011
Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivativesHeather M Bigott-Hennkens, Shorouk F Dannoon, Samantha M Noll, et al.
Bioconjugate Chemistry|November 20, 2003
Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogeneFabio Gallazzi, Yi Wang, Fang Jia, et al.
Nuclear Medicine and Biology|December 10, 2014
Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)LuChi Soo Kang, Yunwei Chen, Hyunbeom Lee, et al.
Nuclear Medicine and Biology|November 26, 2013
Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemiaEthan R Balkin, Dijie Liu, Fang Jia, et al.
Pageof 7